Breast Cancer Tumor Care Observational Programme

Breast Cancer Tumor Care Patient Observation Programme

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00660244

Enrollment

150

Registered

2008-04-17

Start date

2008-02-29

Completion date

2009-12-31

Last updated

2012-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthralgia, Post Menopausal

Keywords

Arimidex, Post menopausal, arthralgia

Brief summary

The purpose of this study is to investigate efficacy and tolerability under anastrozole (Arimidex) treatment.

Interventions

DRUGanastrozole

Oral

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Postmenopausal women * Already on upfront Arimidex Therapy (Start 1-4 weeks before) * HR+

Exclusion criteria

* Premenopausal women * Tamoxifen switch patients

Design outcomes

Primary

Measure	Time frame
Progression of disease and tolerability in general	Baseline, every 3 month

Secondary

Measure	Time frame
Patient questionnaire to collect data on Incidence, time of onset and treatment of arthralgia	Baseline, every 3 month

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026